What's breaking now, across thousands of outlets.
(RTTNews) - SOPHiA GENETICS (SOPH) and Myriad Genetics, Inc. (MYGN) announced Thursday a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (AZN).
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Across Latin America, early-onset cancer rates have risen, but Chile and Brazil have seen the fastest growth, especially with bowel, breast and cervical cancers. But it is a worldwide trend.
Across Latin America, early-onset cancer rates have risen, but Chile and Brazil have seen the fastest growth, especially with bowel, breast and cervical cancers. But it is a worldwide trend.
Mia St Hilaire had a tree nut allergy and suffered an anaphylactic shock after drinking a milkshake.
(MedPage Today) -- Note that some links may require registration or subscription. The owner of a Bronx wellness center where a woman died this summer now faces charges of second degree murder and…
